Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl added to bupivacaine for erector spinae plane block in modified radical mastectomy
PACTR202210738525707Recruiting
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Oct 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fentanyl and bupivacaine in breast cancer (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Total nalbuphine consumption within 24 hours. Started Oct 2022; status: recruiting.
02
Drugs
fentanylbupivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on PACTR202210738525707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202210738525707.